GlassScriptPhysician profile
Tina Bui
NPI 1497107312
$5,632.13
in general payments reported to CMS, 2019-2025
11 companies · $895 in 2025
The $895 reported for 2025 was more than what 89% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $869 · 2020: $377 · 2021: $508 · 2022: $969 · 2023: $1,020 · 2024: $994 · 2025: $895.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,758 · Entertainment: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,757.94 |
| Entertainment | $151.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $2,105.60 | 2022-2025 | Infuse, Miebo, Xiidra |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $1,226.01 | 2019-2021 | |
| Coopervision INC. | $473.52 | 2019-2023 | Myday Contact Lens |
| Glaukos Corporation | $373.44 | 2022-2024 | Photrexa, Idose |
| Johnson & Johnson Vision Care, INC. | $329.58 | 2019-2023 | Acuvue |
| Alcon Vision LLC | $317.96 | 2019-2025 | Wavelight Ex500 Excimer Laser, Total30, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $279.16 | 2025 | Xdemvy |
| Optos, INC. | $151.30 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Sight Sciences, INC. | $148.14 | 2023 | Omni Surgical System |
| Abbvie INC. | $123.62 | 2022 | |
| Rxsight INC | $103.80 | 2024 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.